DBH antibody (N-Term)
Quick Overview for DBH antibody (N-Term) (ABIN372612)
Target
See all DBH AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- Specific for the ~75k DBH protein in Western blots.
-
Cross-Reactivity (Details)
- Species reactivity (tested):Human and non-Human Primates.
-
Purification
- Affinity Chromatography using a Sulfo-Link® column matrix to which the peptide immunogen was coupled.
-
Immunogen
- Peptide from the N-terminal region of human dopamine Beta-hydroxylase (DBH), conjugated to keyhole limpet hemocyanin (KLH).
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Western Blot: 1/1000.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 10 mM HEPES ( pH 7.5), 150 mM NaCl, 100 μg/mL BSA and 50 % Glycerol.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- -20 °C
-
Storage Comment
- Store the antibody undiluted (in aliquots) at-20 °C.
-
-
- DBH (Dopamine beta-Hydroxylase (Dopamine beta-Monooxygenase) (DBH))
-
Alternative Name
- Dopamine beta-Hydroxylase
-
Background
- DBH catalyzes the conversion of dopamine to norepinephrine and serves as a marker of noradrenergic cells. DBH antibodies and antibodies for other markers of catecholamine biosynthesis are widely used as markers for dopaminergic and noradrenergic neurons in a variety of applications including depression, schizophrenia, Parkinson's disease and drug abuse (Kish et al., 2001, Zhu et al., 2000, Zhu et al., 1999). The expression of DBH is also elevated during stress (Sabban and Kvetnansky, 2001).Synonyms: DBH, DBM, DOPO, Dopamine beta-monooxygenase
-
Gene ID
- 1621
-
NCBI Accession
- NP_000778
-
UniProt
- P09172
-
Pathways
- Carbohydrate Homeostasis
Target
-